- Home
- RMAX vs ARTV Comparison
RMAX vs ARTV Comparison
Compare RMAX & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMAX
- ARTV
- Stock Information
- Founded
- RMAX 1973
- ARTV 2019
- Country
- RMAX United States
- ARTV United States
- Employees
- RMAX N/A
- ARTV N/A
- Industry
- RMAX Real Estate
- ARTV
- Sector
- RMAX Finance
- ARTV
- Exchange
- RMAX Nasdaq
- ARTV NYSE
- Market Cap
- RMAX 161.9M
- ARTV 186.1M
- IPO Year
- RMAX 2013
- ARTV 2024
- Fundamental
- Price
- RMAX $8.70
- ARTV $5.10
- Analyst Decision
- RMAX Sell
- ARTV Strong Buy
- Analyst Count
- RMAX 2
- ARTV 6
- Target Price
- RMAX $8.75
- ARTV $21.00
- AVG Volume (30 Days)
- RMAX 177.3K
- ARTV 84.0K
- Earning Date
- RMAX 05-01-2025
- ARTV 03-25-2025
- Dividend Yield
- RMAX N/A
- ARTV N/A
- EPS Growth
- RMAX N/A
- ARTV N/A
- EPS
- RMAX 0.37
- ARTV N/A
- Revenue
- RMAX $307,685,000.00
- ARTV $2,601,000.00
- Revenue This Year
- RMAX N/A
- ARTV N/A
- Revenue Next Year
- RMAX $1.25
- ARTV N/A
- P/E Ratio
- RMAX $23.51
- ARTV N/A
- Revenue Growth
- RMAX N/A
- ARTV N/A
- 52 Week Low
- RMAX $6.94
- ARTV $3.37
- 52 Week High
- RMAX $14.31
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- RMAX 41.50
- ARTV N/A
- Support Level
- RMAX $8.25
- ARTV N/A
- Resistance Level
- RMAX $8.77
- ARTV N/A
- Average True Range (ATR)
- RMAX 0.40
- ARTV 0.00
- MACD
- RMAX -0.00
- ARTV 0.00
- Stochastic Oscillator
- RMAX 40.60
- ARTV 0.00
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.